A series of caudatin ester derivatives were synthesized and tested for their activities against human lung cancer A549, human prostate cancer PC3, human liver cancer BEL-7402 and human gastric cancer SGC-7901 cell lines. All the compounds showed noticeable activities against the tested tumor cell lines, and the IC 50 s are all lower than that of caudatin. Among them, 5e and 5h are the most potent compounds. SAR study implies that introducing either a halogenated acyl group or amino aryl group to the C 3β position of caudatin is beneficial to their anti-viability activities, and the lipophilicity affects the anti-viability activity of caudatin derivatives.
C-21 steroidal glycosides are major active components of the traditional Chinese medicine Cynanchum auriculatum Royle ex Wight. In recent years more than twenty C-21 steroidal glycosides, featuring one to six glycosyl units attached to the 3β-hydroxyl group of caudatin (1) have been isolated from plants [1] , and their antitumor activity has attracted much attention. Due to their chemical diversity and special physico-chemical properties, a single component of a C-21 steroidal glycoside is difficult to isolate and purify, which is great challenge for the research and development of C-21 steroidal glycosides. Moreover, the hemolytic toxicity associated with the sugar chain seems to be another barrier [2a, b] .
During the past years, we have been working on the antitumor pharmacology and semi-synthesis of caudatin. Results showed that the acetylation of caudatin glucosides mostly improved their antiviability activities, e.g. caudatin 3-O-β-D-2,3,4,6-O-tetra-acetyl galactoside (2) [2c,d] . To optimize further its anti-viability activity, we turned our attention to the semi-synthesis of caudatin ester derivatives, using caudatin as the starting material, which is abundant in Cynanchum auriculatum and easily isolated from the plant. We introduced aromatic rings as well as alkyl groups into caudatin at C 3β to take the place of the deoxy glycosyls. The synthetic route for them is outlined in Scheme 1. The ester derivatives were synthesized by the reaction of the corresponding acids with caudatin in the presence of N',N'-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DAMP). The structures of the synthesized derivatives were identified by comparing their spectroscopic data ( 1 H NMR and 13 C NMR) with those of caudatin. All the newly synthesized derivatives of caudatin were tested for their anti-viability activities, namely inhibiting the growth of PC3, SGC-7901, A549 and BEL-7402 cell lines, using taxinol as a positive control. The results are listed in Table 1 . As shown in Table 1 , all the synthesized 3-O-acylated caudatin derivatives exhibited noticeable anti-viability activities against the tested tumor cell lines, and the IC 50 s were lower than that of caudatin. Furthermore, almost all the synthesized compounds were sensitive to the four tested cell lines, which may indicates that caudatin ester derivatives have broad-spectrum anti-viability activities. Among them, compound 5b is significantly sensitive to the A549 cell line with an IC 50 value of 8.08 μM. Compound 5e showed notable anti-viability activities on all tested cell lines with IC 50 values of 4.39 μM on PC3 cells, 2.54 μM on SGC-7901 cells, 5.94 μM on A549 cells, and 9.00 μM on BEL-7402 cells.
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Compound 5h showed anti-viability activities with IC 50 values of 1.65 μM on SGC-7901 cells, 3.35 μM on A549 cells, and 4.10 μM on BEL-7402 cells. Comparison of the anti-viability of compounds 5a, 5b, 5f and 5i reveals that an appropriate aryl group at C 3β of caudatin might be a good target for further lead optimization by introducing rational substitutions. Comparison of the anti-viability of compounds 5b, 5c, 5d, and 5e reveals that introducing a halogen group may increase the anti-viability more than either a carboxyl or a methyl group. By comparing compounds 5f, 5g and 5h, we come to the conclusion that introducing either a hydroxyl or an amino group into the benzoyl group may increase the anti-viability activity significantly.
Comparison of the ClogP values with IC 50 values demonstrates that the lipophilicity affects the anti-viability activity of caudatin derivatives. Figure 3 shows that with an increase in ClogP value, the IC 50 value decreases. The IC 50 value reaches a minimum at ClogP = 4. With further increase of ClogP, however, the IC 50 values increase correspondingly.
In summary, a series of caudatin derivatives were synthesized and examined for their anti-viability activity in vitro against four human tumor cell lines. Compound 5e was the most prominent one with IC 50 values less than 10 μM on all tested tumor cell lines. Compound 5h is another significant one with IC 50 values less than 5 μM on the tested cell lines, except for PC3 cells. SAR study implies that introducing either a halogenated acyl group or amino aryl group to the C 3β position of caudatin is beneficial to their anti-viability activities.
Experimental
General: Reagents and solvents were purchased from commercial sources. Caudatin was extracted from the root of Cynanchum auriculatum. The herb was cut into small pieces and extracted with 95% ethanol at room temperature 3 times, each for 2 h. The ethanol extract was evaporated in vacuum and then partitioned with CHCl 3 under reflux. A yellow residue was obtained by concentrating the CHCl 3 extract. The residue was fractioned by column chromatography using a CHCl 3 -MeOH gradient to give caudatin.
8, 14-O-Isopropylidene caudatin (3):
In a solution of 5 g (0.01 mol) caudatin in acetone (20 mL), 2, 2-dimethoxy propane (20 mL) and a catalytic amount of TsOH were added, and stirred at 50°C under argon for 2 h. Then the mixture was cooled to room temperature and dilute NaHCO 3 solution was added until neutral.
The solution was extracted with CHCl 3 and the CHCl 3 layer was washed with water, dried over anhydrous Na 2 SO 4 , and then evaporated to dryness. The residue was recrystallized from CH 3 OH. Yield 4.8 g, 88.3%.
3-O-Formyl-8, 14-O-isopropylidene caudatin (4a)
: DCC (49.5 mg; 0.24 mmol) was added to a solution of 8, 14-O-isopropylidene caudatin (1) (106 mg; 0.2 mmol), DMAP (4.9 mg; 0.04 mmol), and formic acid (11 mg; 0.24 mmol) in anhydrous CH 2 Cl 2 (8 mL) at 0 . The resulting mixture was stirred at room temperature until the starting material was not observed by TLC. The reaction mixture was filtered, and the residue washed with CH 2 Cl 2 (3×10 mL). The combined CH 2 Cl 2 solution was washed with 5% HCl (3×20 mL), saturated NaHCO 3 (3×20 mL) and brine (3×20 mL), successively. The organic layer was then dried over anhydrous Na 2 SO 4 and concentrated to dryness under reduced pressure. The residue was used for the next step immediately. (5a): The above mentioned product 4a was added to 80% CH 3 COOH (10 mL) for 2 h at room temperature, and then evaporated to dryness. The residue was purified by column chromatography ( ) , 20.9 (CH 3 ), 21.0 (CH 3 ), 24.2 (CH 2 ), 26.9 (CH 2 ), 27.4 (CH 3 ), 31.7 (CH 2 ), 33.4 (CH 2 ), 34.3 (CH 2 ), 37.4 (C), 37.9 (CH 2 ), 38.2 (CH), 38.4 (CH 2 ), 43.6 (CH), 58. 1H, m, H-3 (CH 2 ), 33.4 (CH 2 ), 34.4 (CH 2 ), 37.0 (C), 37.9 (CH 2 ), 38.2 (CH), 38.5 (CH 2 ), 43.6 (CH), 58.1 (C), 71.7 (CH), 74.2 (CH), 74.9 (C), 87.9 (C), 91.4 (C), 112.7 (CH), 112.9 (CH), 117.6 (CH), 119.1 (CH), 119.4 (CH), 129.9 (C), 135.7 (C), 139.0 (CH), 161.7 (C), 166.1 (C), 167.3 (C), 169.6 (C), 209.5 (C Anal. Calcd for C 35 H 47 NO 9 : C, 67.18; H, 7.57; N, 2.24; O, 23.01. Found C, 66.83; H, 7.72; N, 2.35; O, 23 .07.
3-O-Formyl caudatin

3-O-Nicotinyl caudatin (5i):
Compound 5i was prepared from nicotinic acid with the same procedure described for compound 5a to afford white amorphous powder. Yield 91.6 mg, 77%. 1 
3-O-(2-Chloracetyl)-8, 14-O-isopropylidene caudatin (4e):
A solution of 8, 14-O-isopropylidene caudatin (3) 260 mg (0.49 mmol), chloroacetyl chloride 0.7 mL (9.00 mmol) and a catalytic amount of CdCO 3 in dry CH 3 CN was refluxed for 3 h. After filtration, the filtrate was evaporated to dryness. The residue was used for the next step immediately.
3-O-(2-Chloracetyl) caudatin (5e):
The above mentioned product 4e was added to 80% CH 3 COOH (10 mL) for 2 h at room temperature, and then evaporated to dryness. The residue was purified by column chromatography ( 
Antiproliferative activity assay [2e]:
The tumor cell lines (A549, PC3, BEL-7402 and SGC-7901) were obtained from Shanghai Institute of Pharmaceutical Industry. The cytotoxic activity in vitro was measured using the MTT assay. MTT solution (10.0 μL/well) in RPMI-1640 (Sigma, St. Louis, MO) was added after the cells had been treated with drug for 72 h, and the cells were incubated for a further 4 h at 37°C. The purple formazan crystals were dissolved in 100.0 μL DMSO. After 5 min, the plates were read on an automated microplate spectrophotometer (Bio-Tek Instruments, Winooski, VT) at 570 nm. Assays were performed in triplicate in 3 independent experiments. The concentration required for 50% inhibition of cell viability (IC 50 ) was calculated using the software 'Dose-Effect Analysis with Microcomputers'. The tumor cell line panel consisted of A549, PC3, BEL-7402 and SGC-7901. In all of these experiments, 3 replicate wells were used to determine each point.
